B

Biohaven Ltd
D

BHVN

36.270
USD
0.96
(2.72%)
Market Closed
Volume
0
EPS
-9
Div Yield
-
P/E
-4
Market Cap
3,667,703,862
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    A
    AGIO
    -0.380
    (-1.06%)
    35.390 USD
    A
    ALKS
    -0.220
    (-0.73%)
    29.750 USD
    A
    ALLO
    0.03500
    (1.91%)
    1.87000 USD
    B
    BPMC
    1.130
    (1.27%)
    90.120 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    R
    RGNX
    0.22000
    (2.97%)
    7.63000 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Biohaven Ltd

Sector: Healthcare
Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.